Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
iSpecimen ( (ISPC) ) has shared an update.
On February 6, 2026, iSpecimen announced it had successfully completed Milestone 2 of its SalesStack digital transformation program, delivering full system integration and activating a live production marketplace that links customer requests with supplier inventories. The new platform, which incorporates AI-assisted matching, migrated all historical data from the legacy system, enables end-to-end order processing and user management, and is fully connected to internal systems, allowing iSpecimen to streamline operations, cut infrastructure costs tied to its legacy marketplace, improve scalability and performance, and establish a stronger foundation for revenue growth through faster supplier onboarding and more efficient customer service. In a separate February 6, 2026 release, the company also highlighted recent operational achievements across its site network, including rapid influenza specimen procurement, underscoring the responsiveness of its supply base in supporting customer research needs.
The most recent analyst rating on (ISPC) stock is a Sell with a $0.34 price target. To see the full list of analyst forecasts on iSpecimen stock, see the ISPC Stock Forecast page.
Spark’s Take on ISPC Stock
According to Spark, TipRanks’ AI Analyst, ISPC is a Neutral.
The score is weighed down primarily by weak financial performance (sharp TTM revenue decline, margin deterioration, ongoing losses, and persistent cash burn). Technicals add a mixed-to-weak backdrop (below key longer-term moving averages with negative MACD). Corporate events and valuation provide limited offset given Nasdaq bid-price compliance risk and a negative P/E tied to ongoing losses.
To see Spark’s full report on ISPC stock, click here.
More about iSpecimen
iSpecimen Inc. (Nasdaq: ISPC) operates an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens required for medical research and discovery. Its proprietary, cloud-based platform enables researchers to search across a federated network of hospitals, laboratories, biobanks, blood centers and other healthcare organizations to source specimens and associated data.
Average Trading Volume: 1,196,702
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.4M
For an in-depth examination of ISPC stock, go to TipRanks’ Overview page.